174 related articles for article (PubMed ID: 27422997)
21. Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases.
Avula LR; Rudloff M; El-Behaedi S; Arons D; Albalawy R; Chen X; Zhang X; Alewine C
Mol Cancer Res; 2020 Feb; 18(2):229-239. PubMed ID: 31676721
[TBL] [Abstract][Full Text] [Related]
22. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Chang MC; Chen CA; Chen PJ; Chiang YC; Chen YL; Mao TL; Lin HW; Lin Chiang WH; Cheng WF
Biochem J; 2012 Mar; 442(2):293-302. PubMed ID: 21999204
[TBL] [Abstract][Full Text] [Related]
23. Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Carcinogenesis; 2011 Jul; 32(7):1013-24. PubMed ID: 21515913
[TBL] [Abstract][Full Text] [Related]
24. Postchronic Single-Walled Carbon Nanotube Exposure Causes Irreversible Malignant Transformation of Human Bronchial Epithelial Cells through DNA Methylation Changes.
Wang J; Tian X; Zhang J; Tan L; Ouyang N; Jia B; Chen C; Ge C; Li J
ACS Nano; 2021 Apr; 15(4):7094-7104. PubMed ID: 33761739
[TBL] [Abstract][Full Text] [Related]
25. Study on the mesothelin-specific cytotoxicity against epithelial ovarian cancer with full-length mesothelin cDNA-transduced dendritic cells.
Wang DH; Wu XH; Qian SM; Yao HR
Med Oncol; 2015 Apr; 32(4):116. PubMed ID: 25779534
[TBL] [Abstract][Full Text] [Related]
26. Anti-Mesothelin Recombinant Immunotoxin Therapy for Colorectal Cancer.
Cerise A; Bera TK; Liu X; Wei J; Pastan I
Clin Colorectal Cancer; 2019 Sep; 18(3):192-199.e1. PubMed ID: 31345777
[TBL] [Abstract][Full Text] [Related]
27. Synergistic Effect of a Mesothelin-Targeted
Wickstroem K; Hagemann UB; Cruciani V; Wengner AM; Kristian A; Ellingsen C; Siemeister G; Bjerke RM; Karlsson J; Ryan OB; Linden L; Mumberg D; Ziegelbauer K; Cuthbertson AS
J Nucl Med; 2019 Sep; 60(9):1293-1300. PubMed ID: 30850485
[TBL] [Abstract][Full Text] [Related]
28. Mesothelin promotes brain metastasis of non-small cell lung cancer by activating MET.
Xia S; Duan W; Xu M; Li M; Tang M; Wei S; Lin M; Li E; Liu W; Wang Q
J Exp Clin Cancer Res; 2024 Apr; 43(1):103. PubMed ID: 38570866
[TBL] [Abstract][Full Text] [Related]
29. Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer.
Nunes M; Pacheco F; Coelho R; Leitão D; Ricardo S; David L
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162954
[TBL] [Abstract][Full Text] [Related]
30. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells.
Uehara N; Matsuoka Y; Tsubura A
Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228
[TBL] [Abstract][Full Text] [Related]
31. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
[TBL] [Abstract][Full Text] [Related]
32. A novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cells.
Kobayashi K; Sasaki T; Takenaka F; Yakushiji H; Fujii Y; Kishi Y; Kita S; Shen L; Kumon H; Matsuura E
J Immunol Res; 2015; 2015():268172. PubMed ID: 25883990
[TBL] [Abstract][Full Text] [Related]
33. Construction of a
Hou X; Wang F; Meng X; Li D; Ding J; Chen Y; Wang Z; Zhu H; Yang Z
Mol Pharm; 2022 Oct; 19(10):3623-3631. PubMed ID: 35904514
[TBL] [Abstract][Full Text] [Related]
34. Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers.
Hagemann UB; Ellingsen C; Schuhmacher J; Kristian A; Mobergslien A; Cruciani V; Wickstroem K; Schatz CA; Kneip C; Golfier S; Smeets R; Uran S; Hennekes H; Karlsson J; Bjerke RM; Ryan OB; Mumberg D; Ziegelbauer K; Cuthbertson AS
Clin Cancer Res; 2019 Aug; 25(15):4723-4734. PubMed ID: 31064781
[TBL] [Abstract][Full Text] [Related]
35. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation.
Hiraku Y; Guo F; Ma N; Yamada T; Wang S; Kawanishi S; Murata M
Part Fibre Toxicol; 2016 Mar; 13():16. PubMed ID: 27026438
[TBL] [Abstract][Full Text] [Related]
36. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer.
Li M; Bharadwaj U; Zhang R; Zhang S; Mu H; Fisher WE; Brunicardi FC; Chen C; Yao Q
Mol Cancer Ther; 2008 Feb; 7(2):286-96. PubMed ID: 18281514
[TBL] [Abstract][Full Text] [Related]
37. Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.
Lamberts LE; de Groot DJ; Bense RD; de Vries EG; Fehrmann RS
Oncotarget; 2015 Sep; 6(29):28164-72. PubMed ID: 26172299
[TBL] [Abstract][Full Text] [Related]
38. Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo.
Liu G; Zhang Q; Liu G; Li D; Zhang L; Gu Z; Tian H; Zhang Y; Tian X
Exp Cell Res; 2021 Dec; 409(1):112886. PubMed ID: 34673000
[TBL] [Abstract][Full Text] [Related]
39. Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing.
De Santi C; Vencken S; Blake J; Haase B; Benes V; Gemignani F; Landi S; Greene CM
PLoS One; 2017; 12(1):e0170999. PubMed ID: 28125734
[TBL] [Abstract][Full Text] [Related]
40. MALAT-1: LncRNA ruling miR-182/PIG-C/mesothelin triad in triple negative breast cancer.
Barsoum FS; Awad AS; Hussein NH; Eissa RA; El Tayebi HM
Pathol Res Pract; 2020 Dec; 216(12):153274. PubMed ID: 33171372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
